Drug Information Rounds

Pepine CJ Holmes DR Jr Block PC Mullins CE Brinker JA Nissen SE . Coronary artery stents. J Am Coll Cardiol 1996; 28: 782–94.

Serruys PW Di Mario C . Who was thrombogenic: The stent or the doctor? Circulation 1995; 91: 1891–3.

Schatz RA Bairn DS Leon M Ellis SG Goldberg S Hirshfeld JW . Clinical experience with the Palmaz-Schatz coronary stent. Circulation 1991; 83: 148–61.

Serruys PW De Jaegere P Kiemeneij F MaCaya C Rutsch W Heyndrickx G . A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489–95.

Eeckhout E Kappenberger L Goy J . Stents for intracoronary placement: Current status and future directions. J Am Coll Cardiol 1996; 27: 757–65.

Flores-Runk P Raasch RH . Ticlopidine and antiplatelet therapy. Ann Pharmacother 1993; 27: 1090–8.

Lefkovits J Plow EF Topol EJ . Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995; 332: 1553–9.

Schror K . Antiplatelet drugs. Drugs 1995; 50: 7–28.

De Caterina R Sicari R Bernini W Lazzerini G Strata GB Giannessi D . Benefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin. Thromb Haemostas 1991; 65: 504–10.

Colombo A Hall P Nakamura S Almagor Y Maiello L Martini G . Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676–88.

Lablanche J-M McFaddenm EP Bonnet J-L Grollier G Danchin N Bedossa M . Combined antiplatelet therapy with ticlopidine and aspirin. Eur Heart J 1996; 17: 1373–80.

Hall P Nakamura S Maiello L Itoh A Blengino S Martini G . A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996; 93: 215–22.

Goods CM Al-Shaibi KF Liu MW Yadav JS Jain SP Dean LS . Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting. Am J Cardiol 1996; 78: 1042–4.

Serruys PW Emanuelsson H Giessen W Lunn AC Kiemeney F MaCaya C . Heparin-coated Palmaz-Schatz stents in human coronary arteries. Circulation 1996; 93: 412–22.

Schömig A Neumann FJ Kastrati A Schuhlen H Blasini Hadamitzky M . A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084–9.

Popma JJ Coller BS Ohman EM Bittl JA Weitz J Kuntz RE . Antithrombotic therapy in patients undergoing coronary angioplasty. Chest 1995; 108 (4 suppl):486s–501s.

Young LY Koda-Kimble MA , eds. Applied therapeutics: the clinical use of drugs. Vancouver, WA: Applied Therapeutics, Inc., 1995; 48–52–48–53,14–4–14–5,15–33–15–34.

Woo KS Nicholls MG . High prevalence of persistent cough with angiotensin converting enzyme inhibitors in the Chinese. Br J Clin Pharmacol 1995; 40: 141–4.

Zafar H Hall WD . Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. Ann Intern Med 1992; 117: 234–42.

Hargreaves MR . Sodium cromoglycate for ACE inhibitor-induced cough. Br J Clin Pract 1993; 47: 319–20.

Ravid D Lishner M Lang R Ravid M . Angiotensin-Converting enzyme inhibitors and cough: A prospective evaluation in hypertension and in congestive heart failure. J Clin Pharmacol 1994; 34: 1116–20.

Lip GYH Zarifis J Beevers M Beevers DG . Duration of cough following cessation of ACE inhibitor therapy (letter). Am J Hypertens 1995; 8: 98.

Hume AL Murphy JL Lauerman SE . Angiotensin-Converting enzyme inhibitor-induced cough. Pharmacotherapy 1989; 9: 88–90.

Yesil S Yesil M Bayata S Postaci N . ACE inhibitors and cough. Angiology 1994; 45: 805–8.

Eistratopoulus AD Meikopolues M Veyaki S . Frequency of cough during ACE inhibitors in Greek hypertensives. J Hum Hypertens 1993; 7: 607–9.

Charlon V Dollow S Fidel J Hoglund C Honkanen T Kobrin I . Reproducibility of angiotensin converting enzyme inhibitor induced cough: A double-blind randomized study. Br J Clin Pharmacol 1995; 39: 125–9.

Ramsey LE Yoo WW . ACE inhibitors, angiotensin II antagonists and cough. J Hum Hypertens 1995; 9 (Suppl 5):S51–4.

Physicians desk reference 50th ed. Montvale, NJ: Medical Economics Co., 1996: 1628–30,987–90.

Guyton AC . Textbook of medical physiology. Philadelphia: WB Saunders Co., 1996: 206–7.

Cascieri MA Bull HG Mumfort RA . Carboxylterminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin converting enzyme and the potentiation of substance P activity in vivo by Captopril and MK-422. Mol Pharmacol 1984; 25: 287–93.

Yokosawa H Endo S Ohgaki Y Maeyama J Ishii S . Hydrolysis of substance P and its analogs by angiotensin-converting enzyme from rat lung. Characterization of endopeptidase activity of the enzyme. J Biochem 1985; 98: 1293–9.

Rigat B Hubert C Athenc-Gelas F Cambien F Corvol P Soubrier F . An insertion/deletion polymorphism in the angiotensin 1 -converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343–6.

Yeo WW Ramsay LE Morice AH . ACE inhibitor cough: A genetic link (letter)? Lancet 1991; 337: 187.

Nicholls MG Gilchrist NL . Sulindac and cough induced by converting enzyme inhibitors (letter). Lancet 1987: 872.

Gilchrist NL Richards AM March R Nicholls MG . Effect of sulindac on ACE inhibitor-induced cough: Randomized placebo-controlled double blind cross-over study. J Hum Hypertens 1989; 3: 451–5.

Fogari R Zoppi A Tettamanti F Malamani GD Tinelli C Salvetti A . Effects of nifedipine and indomethicin on cough induced by angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1992; 19: 670–3.

McEwan JR Choudry NB Fuller RW . The effects of sulindac on the abnormal cough reflex associated with dry cough. J Pharmacol Exp Ther 1990; 255: 161–4.

Olson C . Delay in diagnosis and empiric treatment of angiotensin-converting enzyme inhibitor induced cough in office practice. Arch Fam Med 1995; 4: 525–8.

Brown RC Turton CGW . Cough and angiotensin converting enzyme inhibition (letter). BMJ 1988; 296: 1741.

Pomari C Turco P Negro RD . Has theophylline a role in the cure and prevention of ACE-inhibitor-related cough? Respiration 1989; 55: 119–21.

Cazzola M Matera MG Liccardi G De Pisco F D'Amato G Rossi F . Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough. Respiration 1993; 60: 212–5.

Gilman AG Rall TW Nies AS , eds. Goodman and Gilman's the pharmacologic basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 630–1.

Keogh A . Sodium cromoglycate prophylaxis for angiotensin-converting enzyme inhibitor cough (letter). Lancet 1993; 341: 560.

Aldis WL . Cromolyn for cough due to angiotensin-converting enzyme inhibitor therapy. Chest 1991; 100: 1741–2.

Jayasuriya PH . Sodium cromoglycate for ACE inhibitor cough. Med J Aust 1992; 156: 363–4.

Hargreaves MR Benson MK . Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough. Lancet 1995; 345: 13–6.

Puolijoki H Rekiaro M . Lack of effect of nedocromil sodium in ACE-inhibitor-induced cough. Lancet 1995; 345: 394–5.

Sahn SA Lakshminarayan S . Tuberculosis after corticosteroid therapy. Br J Dis Chest 1976; 70: 195–205.

American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359–74.

Bateman ED Wolmarans KH White NW Ainslie GM . Corticosteroid treatment and the risk of active tuberculosis in patients with chronic interstitial lung disease (abstract). Am Rev Respir Dis 1991; 143: A54.

Cowie RL King LM . Pulmonary tuberculosis in corticosteroid-treated asthmatics. S Afr Med J 1987; 72: 849–50.

Haanaes OC Bergmann A . Tuberculosis emerging in patients with corticosteroids. Eur J Respir Dis 1983; 64: 294–7.

Schatz M Patterson R Kloner R Falk J . The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population. Ann Intern Med 1976; 84: 261–5.

Cisneros JR Murray KM . Corticosteroids in tuberculosis. Ann Pharmacother 1996; 30: 1298–1303.

Allen MB Cooke NJ . Corticosteroids and tuberculosis. BMJ 1991; 303: 871–2.

Starke JR . Current chemotherapy for tuberculosis in children. Infect Dis Clin North Am 1992; 6: 215–38.

Carrie F Roblot P Bouquet S Delon A Roblot F Becq-Giraudon B . Rifampin-induced nonresponsiveness of giant cell arteritis to prednisone treatment. Arch Intern Med 1994; 154: 1521–4.

Phillipson EA . Disorders of ventilation. In: Wilson JD Braunwald E Isselbacher KJ Petersdorf RG Martin JB Fauci AS , eds. Harrison's principles of internal medicine. New York: McGraw-Hill, 1991: 1119–21.

Kryger MH Roth T Dement WC , eds. Principles and practice of sleep medicine. Philadelphia: WB Saunders Co., 1994: 1–60.

Hudgel DW . Treatment of obstructive sleep apnea. Chest 1996; 109: 1346–58.

Strollo PJ Rogers RM . Obstructive sleep apnea. N Engl J Med 1996; 334: 99–104.

Cistulli PA Barnes DJ Grunstein RR Sullivan CE . Effect of short term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 1994; 49: 699–702.

Block JA Wynne JW Boysen PG Lindsey S Martin C Cantor B . Menopause, medroxyprogesterone and breathing during sleep. Am J Med 1981; 70: 506–10.

Hanzel DA Proia NG Hudgel DW . Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 1991; 100: 416–21.

Sharp JT Druz WS D'Souza V Diamond E . Effect of metabolic acidosis upon sleep apnea. Chest 1985; 87: 619–24.

Shore ET Millman RP . Central sleep apnea and acetazolamide therapy (letter). Arch Intern Med 1983; 143: 1278.

Skatrud JB Dempsey JA Kaiser DG . Ventilatory response to medroxyprogesterone acetate in normal subjects: Time course and mechanism. J Appl Physiol 1978; 44: 939–44.

Collop NA . Medroxyprogesterone acetate and ethanol-induced exacerbation of obstructive sleep apnea. Chest 1994; 106: 792–9.

Rajagopal KR Abbrecht PH Jabbari B . Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest 1986; 90: 815–21.

Strahl KP Hensley MJ Saunders NA Scharf SM Brown R Ingram RH . Progesterone administration and progressive sleep apneas. JAMA 1981; 245: 1230–2.

Cook WR Benich JJ Wooten SA . Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Chest 1989; 96: 262–6.

Franklin K Lundgren R Rabben T . Sleep apnoea syndrome treated with oestradiol and cyclic medroxyprogesterone. Lancet 1991; 338: 251–2.